RT Book, Section
A1 Benenson, Shmuel
A2 DeCherney, Alan H.
A2 Nathan, Lauren
A2 Laufer, Neri
A2 Roman, Ashley S.
SR Print(0)
ID 56974017
T1 Chapter 44. Antimicrobial Chemotherapy
T2 CURRENT Diagnosis & Treatment: Obstetrics & Gynecology, 11e
YR 2013
FD 2013
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-163856-2
LK accessmedicine.mhmedical.com/content.aspx?aid=56974017
RD 2024/04/19
AB Microbial  infection  has  always  been  a  grave  threat  to  obstetric  and  gynecologic  patients.  Developments  in  antimicrobial  therapy,  however,  have  led  to  decreases  in  puerperal  and  postoperative  morbidity  and  perinatal  mortality.  Indeed  antibiotic  development  is  one  of  the  most  important  advances  in  medicine  in  the  20th  century.  Empiric  antibiotics  for  bacterial  infections  improve  clinical  symptoms  and  outcome.  As  a  consequence,  clinicians  prescribe  antibiotics  very  frequently  and  sometimes  even  when  it  is  not  necessary.  This  approach  has  led  to  huge  overuse  of  antibiotics,  which  in  turn  has  led  to  the  appearance  of  multidrug-resistant  bacteria.  Clinicians  need  to  adopt  an  approach  where  effective  antibiotic  treatment  is  given  to  those  who  have  bacterial  infections,  while  at  the  same  time  antibiotic  use  is  limited  when  not  indicated.